Clinical trials
Monitoring clinical trials
Below are recruiting monitoring clinical trials, each written for real people, not researchers. We’re tracking 1,257 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07061366Recruiting
Using the Bambi-Belt for very premature babies
This study tests a special belt called the Bambi-Belt in extremely preterm babies (born before 26 weeks) during their first week of life. The goal is to see if the belt helps provide better care and monitoring. It may be an option for your baby if they are very early and do not have skin problems or need only comfort care.
AmsterdamAges Up to 1 week - NCT07061301Recruiting
Leaving the hospital with insulin: a transition study
This study helps people with type 2 diabetes who just started using insulin in the hospital get ready to go home. It tests whether extra support and tools like a smart insulin cap and a continuous glucose monitor make the switch safer and easier.
Valencia, ValenciaAges 18–70 - NCT07062744Recruiting
Swan-Ganz catheter for cardiogenic shock after heart attack
This study tests whether a special catheter (Swan-Ganz) placed in the heart's blood vessels helps doctors better manage fluids and medications for people in cardiogenic shock after a heart attack. It aims to improve blood flow to vital organs.
HanoiAges 18 years+ - NCT07064733Recruiting
Music or Warm Foot Bath for Pregnancy Anxiety
This study tests whether listening to music or soaking your feet in warm water can help lower pregnancy-related anxiety, improve your blood pressure, and boost your quality of life. It's designed for women with a healthy, low-risk pregnancy.
EdirneAges 18–39 - NCT07073456Recruiting
Blood clotting test for early sepsis detection
This study is testing a new blood test that looks at how well your blood clots to see if it can help find sepsis (a severe response to infection) earlier. It is for adults who might have an infection, but you cannot be taking certain medications or have certain health conditions.
Chaïdári, AtticaAges 18 years+ - NCT07074028Recruiting
Tracking muscle changes in ICU patients with sepsis
This study is for people in the ICU with sepsis who need a breathing machine for a long time. It monitors muscle changes during recovery to understand how sepsis affects muscles.
Saint-BrieucAges 18 years+ - NCT07081399RecruitingEarly Phase 1
Care plan to prevent complications after tube removal
This trial tests a special care plan for adults who are on a breathing machine (ventilator) for the first time. The goal is to see if this plan helps prevent problems after the breathing tube is removed.
Damanhūr, EgyptAges 18–60 - NCT07084935Recruiting
Comparing pain monitors during children’s surgery
This trial compares two devices that measure pain levels during surgery in children. It may help doctors better manage pain for children having planned surgery with general anesthesia.
Nijmegen, GelderlandAges 1–12 - NCT07087353Recruiting
Remote monitoring for moderate to severe depression
This study tests whether checking in with a mental health team remotely (using your phone) can help people with moderate to severe depression feel better. It’s designed for people who are already getting treatment and want extra support from home.
BesançonAges 18 years+ - NCT07092644Recruiting
Preeclampsia and baby heart defects: mother's heart study
This study looks at the link between preeclampsia (a pregnancy complication with high blood pressure) and a mother's heart health when her baby has a heart problem. The goal is to understand how the mother's heart adapts during pregnancy in these cases.
RomaAges 18 years+ - NCT07095166Recruiting
Studying eating habits in healthy kids ages 6-9
This study looks at how and when children eat. It uses a special scan and asks parents about their child's mealtimes to learn about healthy eating patterns.
State College, PennsylvaniaAges 6–9 - NCT07101926Recruiting
Monitoring anti-TFPI in severe hemophilia patients on Marstacimab
This study looks at how a medicine called Marstacimab affects your body's natural anti-clotting protein (TFPI) in people with severe hemophilia A or B who are already taking it. It involves blood tests to see how well the treatment works.
BronAges 18 years+ - NCT07103733Recruiting
Adding MRI and monitoring to mitral valve repair study
This study is for people already in the PRIMARY trial who are having mitral valve repair surgery. It adds an extra MRI scan and possibly a heart rhythm monitor to learn more about heart recovery after repair.
Los Angeles, CaliforniaAges 60 years+ - NCT07111182Recruiting
Using a Dye to Guide Brain Tumor Surgery
This study tests whether a special dye called 5-ALA can help surgeons see tumor tissue more clearly during brain tumor surgery. If you are having surgery for a high-grade glioma or another brain tumor, you may be able to join and help improve surgical precision.
Chicago, IllinoisAges 18–99 - NCT07111585Recruiting
Personal health coaching for heart failure patients
This study tests whether personalized health coaching helps people who are frail and have been hospitalized for heart failure. If you are 40 or older, recently in the hospital for heart failure, and feeling weak or vulnerable, this program may support your recovery.
IncheonAges 40 years+ - NCT07111858Recruiting
Pavlik harness vs monitoring for hip dysplasia in babies
This trial compares using a soft brace (Pavlik harness) versus simply monitoring for babies diagnosed with a certain type of hip condition (Graf type 2b or 2c). Researchers want to see which approach leads to better hip development and avoids the need for more intensive treatment.
Royal Tunbridge WellsAges birth–4 months - NCT07123038Recruiting
Long-term safety study for gene-modified Treg therapy recipients
This study follows people who previously received a gene-modified Treg (regulatory T cell) therapy from Sonoma Biotherapeutics. It checks for long-term safety and does not involve any new treatment.
San Francisco, CaliforniaAges 18–71 - NCT07125079Recruiting
Studying immune cells and a new treatment for ARDS
This study looks at how the immune system responds in people with ARDS (a severe lung injury) and tests a new treatment called PIP-2 in the lab to see if it might help. It aims to better understand lung injury and find new ways to treat it.
Philadelphia, PennsylvaniaAges 21–90 - NCT07130799Recruiting
Monitoring immune response in severe abdominal infections with fungal risk
This trial monitors a marker of immune function (monocyte HLA-DR) in patients with severe abdominal infections that may lead to fungal infections. It aims to see if this marker can help guide treatment.
Vandœuvre-lès-NancyAges 18 years+ - NCT07131007Recruiting
Early warning system for immunotherapy side effects
This study is for people with cancer who are already receiving immunotherapy (checkpoint inhibitors). It aims to build an early warning system to help detect and manage possible organ damage or other side effects from the treatment, using advanced testing to keep you safer.
Shijiazhuang, HebeiAges 18–80 - NCT07131670Recruiting
Tracking symptoms during lung cancer chemoradiation
This study uses an app to track symptoms like pain and fatigue in patients with advanced lung cancer receiving chemotherapy and radiation. The goal is to see if digital check-ins can improve care and quality of life.
Wuhan, HubeiAges 18 years+ - NCT07131774Recruiting
Tracking symptoms for lung NTM infections
This trial uses a simple symptom diary to monitor how people with lung NTM infections are feeling over time, either on or off antibiotics. It helps doctors understand treatment effects better.
Freiburg im Breisgau, Baden-WurttembergAges 18 years+ - NCT07144228Recruiting
Platelet test for finding and tracking prostate cancer
This trial studies a new blood test that looks at platelets (a part of your blood) to help find prostate cancer or keep track of it. You may join if you are a man over 40 with a suspicion of prostate cancer who has not been treated for it before.
Durham, North CarolinaAges 40 years+ - NCT07148739RecruitingPhase 4
Ensuring Best Access to CF Treatment
This study tests whether people with cystic fibrosis who are already on a triple combination CFTR modulator can stay on their treatment without interruptions or problems. It aims to make sure everyone gets the best, most consistent treatment for their CF.
Birmingham, AlabamaAges 3 years+
Hear when a new Monitoring trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for monitoring?
- Yes. Clin2 currently lists 1,257 recruiting monitoring studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a monitoring trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a monitoring trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.